Our study revealed that SHH signal pathways were aberrantly activated in lung cancer tissues and cells which conferred more proliferative and invasive phenotypes to human lung cancer cells and leading to adverse prognosis in patients (Fig. 1). This evidence concerns the gene SHH and lung carcinoma.